A clinical trial of dextromethorphan in amyotrophic lateral sclerosis
Introduction - Although the cause of amyotrophic lateral sclerosis (ALS) is unknown, excitotoxicity mediated by glutamate has been implicated. Dextromethorphan is a NMDA-glutamate receptor antagonist with neuroprotective properties. Material and methods - The effect of treatment with dextromethorpha...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | 英語 |
| 出版事項: |
2009
|
| オンライン･アクセス: | https://doi.org/10.1111/j.1600-0404.1997.tb00231.x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|